Hostname: page-component-7479d7b7d-68ccn Total loading time: 0 Render date: 2024-07-11T01:19:12.257Z Has data issue: false hasContentIssue false
  • English
  • Français

Apical hypertrophic cardiomyopathy with subendocardial late gadolinium enhancement in an adolescent

Published online by Cambridge University Press:  30 December 2020

Simona Boroni Grazioli Open the ORCID record for Simona Boroni Grazioli [Opens in a new window] ,
Marc-Philip Hitz  and
Inga Voges
Simona Boroni Grazioli
Affiliation:
Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany
Marc-Philip Hitz
Affiliation:
Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany Department for Human Genetics, University Hospital Schleswig-Holstein, Kiel, Germany
Inga Voges*
Affiliation:
Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany
*
Author for correspondence: Dr Inga Voges. Department of Congenital Heart Disease and Pediatric Cardiology, Arnold-Heller-Str. 3, Haus 9, University Hospital Schleswig-Holstein, Campus Kiel. Tel: +49(0)43150025602; Fax: +49(0)43150025604. E-mail: inga.voges@uksh.de
Get access Rights & Permissions [Opens in a new window]

Abstract

A 17-year-old boy with a history of dyspnea attacks and chest pain was referred to our paediatric cardiology department. Electrocardiogram at presentation showed T-wave inversion in the inferior leads. Cardiovascular magnetic resonance imaging revealed the rare diagnosis of apical hypertrophic cardiomyopathy with subendocardial late gadolinium enhancement, missed by echocardiography.

Keywords

Pediatric cardiomyopathycardiovascular magnetic resonancegenetics
Type
Images in Congenital Cardiac Disease
Information
Cardiology in the Young , Volume 31 , Issue 2 , February 2021 , pp. 286 - 288
Check for updates
Copyright
© The Author(s), 2020. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hughes, RK, Knott, K, Malcomoson, J, et al. Apical hypertrophic cardiomyopathy: the variant less known. J Am Heart Assoc 2020; 9: e015294.CrossRefGoogle ScholarPubMed
Kitaoka, H, Doi, Y, Casey, SA, Hitomi, N, Furuno, T, Maron, BJ. Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol 2003; 92 (10): 1183–1186.CrossRefGoogle ScholarPubMed
Miyamoto, T, Horigome, H, Kawano, S, Sumazaki, R. Apical hypertrophic cardiomyopathy in childhood: a long-term follow-up report of two cases. Pediatr Cardiol 2009; 30: 343–346.CrossRefGoogle ScholarPubMed
Zhao, QM, He, L, Liu, F. Apical hypertrophic cardiomyopathy: an uncommon cause of exertional chest pain in children. Cardiol Young 2019; 29 (12): 1533–1535.CrossRefGoogle ScholarPubMed
Zein, RK, Al-Faham, Z, Mouabbi, JA, and Daher, ER. An uncommon variant of an uncommon disease: a caucasian adolescent with apical hypertrophic cardiomyopathy diagnosed with myocardial perfusion imaging. World J Nucl Med 2017; 16 (3): 251–254.CrossRefGoogle ScholarPubMed
Maurizi, N, Passantino, S, Spaziani, G, et al. Long-term outcomes of pediatric-onset hypertrophic cardiomyopathy and age-specific risk factors for lethal arrhythmic events. JAMA Cardiol 2018; 3 (6): 520–525.CrossRefGoogle ScholarPubMed
Kim, KH, Kim, HK, Hwang, IC, et al. Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with “pure” apical hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2012; 14 (1): 52.CrossRefGoogle ScholarPubMed
Neubauer, S, Kolm, P, Ho, CY, et al. Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry. J Am Coll Cardiol 2019; 74 (19): 2333–2345.CrossRefGoogle ScholarPubMed
Kebed, KY, Al Adham, RI, Bishu, K, et al. Evaluation of apical subtype of hypertrophic cardiomyopathy using cardiac magnetic resonance imaging with gadolinium enhancement. Am J Cardiol 2014; 114 (5): 777–782.CrossRefGoogle ScholarPubMed
Amano, Y, Tacheda, M, Tachy, M et al. Myocardial fibrosis evaluated by look–locker and late gadolinium enhancement magnetic resonance imaging in apical hypertrophic cardiomyopathy: association with ventricular tachyarrhythmia and risk factors. J Magn Reson Imaging 2014; 40: 407–412.CrossRefGoogle ScholarPubMed
Dato, I. How to recognize endomyocardial fibrosis? J Cardiovasc Med 2015; 16: 547–551.CrossRefGoogle ScholarPubMed